Clinical Trial Update: Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia [Phase 3]

View source ↗

Summary

A Phase 3 trial of inotuzumab ozogamicin with frontline chemotherapy for newly diagnosed B-cell acute lymphoblastic leukemia in young adults has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: B Acute Lymphoblastic Leukemia | Phase 3 | Status: SUSPENDED